

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its promising drug candi...


(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saa...


(Alliance News) - AstraZeneca PLC and Daiichi Sanyko Co Ltd on Monday reported that their co-developed breast cancer treatment Enhertu had secure prio...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


* GLP-1 drugs reduced substance use disorders in patients with type 2 diabetes.


Feb 27 (Reuters) - London's FTSE 100 climbed to a record high on Friday, boosted by heavyweight miners and defensive stocks while Barclays slumped ...


(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion.


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: